IHC - HEPATITIS B CORE ANTIGEN (HBCAG)

The IHC – Hepatitis B Core Antigen (HBcAg) test is a specialized immunohistochemistry (IHC) test used to detect the presence of Hepatitis B Core Antigen (HBcAg) in liver tissue samples. This test plays an important role in diagnosing Hepatitis B virus (HBV) infection and evaluating its activity within liver cells.

HBcAg is a viral protein found inside liver cells infected by the Hepatitis B virus. Detecting this protein helps pathologists confirm active viral presence in liver tissue and assess the extent of infection-related liver damage. This test is usually performed on liver biopsy samples and is often used when blood test findings require tissue-level confirmation.

The HBcAg IHC test provides valuable information for diagnosing chronic Hepatitis B, monitoring disease progression, and assessing treatment response. It helps doctors understand how actively the virus is replicating within the liver and whether liver cells are being affected.

Benefits of the Test

The IHC HBcAg test offers several important benefits:

• Detects active Hepatitis B infection in liver tissue
• Confirms viral presence at the cellular level
• Helps evaluate liver disease severity
• Supports diagnosis of chronic Hepatitis B
• Assists in monitoring antiviral treatment response
• Helps guide long-term liver disease management

This test provides direct tissue evidence of HBV infection, improving diagnostic precision.

Why Doctors Recommend This Test

Doctors recommend the HBcAg IHC test when blood investigations suggest Hepatitis B infection but additional tissue confirmation is needed. It is especially useful in patients with:

• Chronic Hepatitis B infection
• Unexplained liver inflammation
• Abnormal liver biopsy findings
• Suspected active viral replication
• Liver damage requiring detailed viral assessment

This test helps hepatologists and pathologists determine disease activity and guide treatment planning.

Preparation Before Test

No special preparation is needed for the IHC test itself. It is performed on previously collected liver biopsy tissue samples. Patients should follow their doctor’s instructions related to biopsy preparation and aftercare.

Normal Reporting Time

The normal reporting time for the HBcAg IHC test is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients diagnosed with chronic Hepatitis B
• Individuals with abnormal liver biopsy findings
• Patients with suspected active HBV replication
• Cases requiring tissue-level viral confirmation
• Individuals undergoing detailed liver disease evaluation

The IHC HBcAg test is an important diagnostic tool in liver pathology. It helps confirm Hepatitis B virus activity within liver cells and provides valuable insights into disease severity and progression. Accurate detection supports timely treatment decisions and improves long-term patient care.